Canada Markets closed

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
35.59+1.04 (+3.01%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.41
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 387.24
52 Week Low 319.38
50-Day Moving Average 336.80
200-Day Moving Average 349.84

Share Statistics

Avg Vol (3 month) 3911.26k
Avg Vol (10 day) 3652.99k
Shares Outstanding 537.56M
Implied Shares Outstanding 6N/A
Float 829.63M
% Held by Insiders 121.40%
% Held by Institutions 161.32%
Shares Short (Aug. 12, 2021) 43.4M
Short Ratio (Aug. 12, 2021) 42.61
Short % of Float (Aug. 12, 2021) 415.21%
Short % of Shares Outstanding (Aug. 12, 2021) 49.02%
Shares Short (prior month Jul. 14, 2021) 42.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-40.21%
Return on Equity (ttm)-100.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -107.48M
Net Income Avi to Common (ttm)-113.63M
Diluted EPS (ttm)-2.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)141.22M
Total Cash Per Share (mrq)3.75
Total Debt (mrq)50.05M
Total Debt/Equity (mrq)70.07
Current Ratio (mrq)6.20
Book Value Per Share (mrq)3.05

Cash Flow Statement

Operating Cash Flow (ttm)-88.9M
Levered Free Cash Flow (ttm)-46.04M